Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and <scp>meta‐analysis</scp>

Abdulrehman, Jameel; Elbaz, Carolyne; Aziz, David; Parpia, Sameer; Fazelzad, Rouhi; Eischer, Lisbeth; Rodger, Marc; Cannegieter, Suzanne C.; Cate‐Hoek, Arina J. ten; Nagler, Michael; Schulman, Sam; Rezende, Suely Meireles; Olié, Valérie; Palareti, Gualtiero; Marcucci, Maura; Douketis, James D.; Poli, Daniela; Ząbczyk, Michał; Sousa, Diana Aguiar de; Miranda, Bruno; Cushman, Mary; Tosetto, Alberto; Gal, Grégoire Le; Kearon, Clive; Skeith, Leslie

doi:10.1111/bjh.18331

Cited by 9 publications

(1 citation statement)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In women with idiopathic VTE, if up to one of the following risk factors was identified, the risk of recurrence of VTE was significantly lower: (1) older age (≥65 years), ( 2) obesity (BMI ≥ 30 kg/m 2 ), (3) increased D-dimer before stopping warfarin therapy, and (4) signs of post-thrombotic syndrome. The risk of recurrence after discontinuation of anticoagulation for a combined oral contraceptive-associated VTE was low, and this was lower than after an unprovoked VTE [119]. Persistently elevated D-dimer after discontinuation of anticoagulant therapy, age group over 50 years, male sex, and VTE unrelated to hormonal therapy (in women) increased the risk of recurrence of idiopathic VTE in the DASH prediction score [120].…”

Section: Venous Thromboembolismmentioning

confidence: 94%

Vascular Diseases in Women: Do Women Suffer from Them Differently?

Farkas,

Stanek,

Zbinden

et al. 2024

JCM

View full text Add to dashboard Cite

According to the World Health Organization, cardiovascular disease (CVD) is the leading cause of death among women worldwide, yet its magnitude is often underestimated. Biological and gender differences affect health, diagnosis, and healthcare in numerous ways. The lack of sex and gender awareness in health research and healthcare is an ongoing issue that affects not only research but also treatment and outcomes. The importance of recognizing the impacts of both sex and gender on health and of knowing the differences between the two in healthcare is beginning to gain ground. There is more appreciation of the roles that biological differences (sex) and sociocultural power structures (gender) have, and both sex and gender affect health behavior, the development of diseases, their diagnosis, management, and the long-term effects of an illness. An important issue is the knowledge and awareness of women about vascular diseases. The risk of cardiovascular events is drastically underestimated by women themselves, as well as by those around them. The purpose of this review is to draw attention to improving the medical care and treatment of women with vascular diseases.

show abstract

Section: Venous Thromboembolismmentioning

confidence: 94%